Perrigo Co 

PRGO:NASDAQ

LastChange / % ChangeDividend YieldVolume
67.06 0.9000   1.36%0.42%625,366

Market data is delayed by at least 20 minutes.

Exclusive Features

When you open a Scottrade account, you will be able to trade, add stocks to a watch list, set alerts and get real-time quotes.

For full analysis details, Log In with Scottrade or you can:
  •  
    Advanced Charts

  •  
    Embed Chart

    Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

  • 1 Day
  • 5 Day
  • 6 Mo
  • 1 Yr
  • 5 Yr
 
 
 

Latest News Headlines for Perrigo Co

Perrigo Company Will Release Second Quarter Fiscal 2011 Results on February 1, 2011
4 hours 26 minutes ago - PR Newswire
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it will release financial results for its second quarter fiscal 2011 on Tuesday, February 1, 2011 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman and Chief Executive Officer.
Watch for Perrigo to Potentially Pullback after Gaining 1.36% Yesterday (PRGO)
18 hours 17 minutes ago - Comtex SmarTrend(R)
Perrigo (NASDAQ:PRGO) traded in a range yesterday that spanned from a low of $65.59 to a high of $67.47. Yesterday, the shares gained 1.36%, which took the trading range above the 3-day high of $67.46 on volume of 616,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Potential Perrigo (PRGO) Trade Has $60.65 Breakeven
4 days 11 hours 39 minutes ago - FreshBrewedMedia
Perrigo (NASDAQ: PRGO) closed Wednesday's trading session at $66.15. In the past year, the stock has hit a 52-week low of $41.22 and 52-week high of $68.38. Perrigo stock has been showing support around $65.28 and resistance in the $67.90 range. Technical indicators for the stock are Bullish. For a hedged play on this stock, look at the May '11 $65.00 covered call for a net debit in the $60.65 area. That is also the break-even stock price for this trade. This covered call has a duration of 128 days, provides 8.31% downside protection and an assigned return rate of 7.17% for an annualized return rate of 20.45% (for comparison purposes only). Perrigo has a current annual dividend yield of 0.42%.
View more recent headlines
 
 
 
 
 
 
More Filings

Latest Annual and Quarterly SEC Filings

10-K
August 12, 2010
This report contains detailed information about the company's business finances and management.
10-Q
November 2, 2010
Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)
 
 
 
Company Background
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, infant formulas, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is a store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Perrigo Company operates through several wholly owned subsidiaries. On February 26, 2010, the Company completed the sale of its Israel Consumer Products business to Emilia Group, a subsidiary of O. Feller Holdings Ltd. On April 30, 2010, the Company acquired 100% of the shares of PBM Holdings, Inc.
Bid/Size
-- / --
Ask/Size
-- / --
Price Open
66.07
Previous Close
66.16
Day High
67.47
Day Low
65.59
52wk High/Date
68.38 / 11/2/2010
52wk Low/Date
41.25 / 1/26/2010
Beta
0.80
Market Capitalization
6.19B
Shares Outstanding
92.23M
Volatility Avg
32.12
Avg Vol(10 day)
656.66K
P/E Ratio
26.3x
EPS (TTM)
2.55
Annualized Rate
-- / --
Yield
0.42%
Dividend Announcement
10/27/2010
Ex-Date
11/23/2010
Date of Record
11/26/2010
Payable
0.07 - QRTR
Payable Date
12/14/2010
Last Trade as of 1/14/2011 4:00 PM ET

Exclusive Content

When you open an account with Scottrade, you will get premium content on the News & Content page, including:

  • Standard & Poor's News and Commentary
  • Dow Jones News
  • Briefing News and Commentary
  • Market Edge On the Edge Commentary
For full analysis details, Log In with Scottrade or you can:
 
 
 

PRGO Perrigo Co vs. Peers

Peers 
PRGO
Perrigo Co
5.89%
TAROF
Taro Pharmaceutical Industries Ltd.
1.79%
PRGO
Perrigo Co
0.42%
TAROF
Taro Pharmaceutical Industries Ltd.
--
PRGO
Perrigo Co
1.36%
TAROF
Taro Pharmaceutical Industries Ltd.
-0.20%
Compare these stocks
 
 
 
© 2011 Scottrade

Brokerage Products and Services offered by Scottrade, Inc. - Member FINRA and SIPC

Online market and limit stock trades are just $7 for stocks priced $1 and above.

Any specific securities, or types of securities, used as examples are for demonstration purposes only. No information on this Web site should be considered a recommendation or None of the information provided should be considered a recommendation or solicitation to invest in, or liquidate, a particular security or type of security.

Investors should consider the investment objectives, risks, and charges and expenses of a mutual fund carefully before investing. A mutual fund's prospectus contains this and other information about the mutual fund. Prospectuses are available through our trading site or through a Scottrade Branch Office. The prospectus should be read carefully before investing. No transaction fee (NTF) funds are subject to the terms and conditions of the NTF funds program. Scottrade is compensated by the funds participating in the NTF program through recordkeeping, shareholder, or SEC 12b-1 fees.

Investors should consider the investment objectives, charges, expense, and unique risk profile of an Exchange Traded Fund (ETF) carefully before investing. Leveraged and Inverse ETFs may not be suitable for long-term investors and may increase exposure to volatility through the use of leverage, short sales of securities, derivatives and other complex investment strategies. A prospectus contains this and other information about the ETF and should be obtained from the issuer. The prospectus should be read carefully before investing.

Margin trading involves interest charges and risks, including the potential to lose more than deposited, or the need to deposit additional collateral in a falling market. Margin Disclosure Statement (PDF) is available for download, or it is available at one of our branch offices. It contains information on our lending policies, interest charges, and the risks associated with margin accounts.

Options involve risk and are not suitable for all investors. Detailed information on our policies and the risks associated with options can be found in the Scottrade Options Application and Agreement, Brokerage Account Agreement, and by downloading the Characteristics and Risks of Standardized Options and Supplements (PDF) from The Options Clearing Corporation, or by requesting a copy from your local branch office. Supporting documentation for any claims will be supplied upon request.

Market volatility, volume, and system availability may impact account access and trade execution.

Testimonials may not be representative of the experience of other clients and are no guarantee of future performance or success.